Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Antivenin (micrurus fulvius)
Drug ID BADD_D00150
Description North American Coral Snake Antivenin (Equine) is a horse-derived antivenin indicated for the treatment of envenomation caused by North American coral snake bites. It is intravenously administered so that the antivenin binds to and neutralizes coral snake venom. The antivenin is a refined, concentrated, and lyophilized preparation of serum globulins obtained by fractionating blood from healthy horses that have been immunized with eastern coral snake (Micrurus fulvius fulvius) venom [FDA Label]. Prior to lyophilization, the product contains 0.25% phenol and 0.005% thiomerosal (mercury derivative) [FDA Label].
Indications and Usage This particular antivenin is indicated only for the treatment of envenomation caused by bites from Eastern coral snakes (Micrurus fulvius fulvius) and Texas coral snakes (Micrurus fulvius tenere) [FDA Label, L2176]. The agent will not neutralize the venom of Arizona (Sonoran) coral snakes (Micruroides euryxanthus) or that of South American species [FDA Label, L2176].
Marketing Status approved; experimental
ATC Code Not Available
DrugBank ID DB13883
KEGG ID D02962; D02961; D02963
MeSH ID D000997
PubChem ID Not Available
TTD Drug ID Not Available
NDC Product Code 0008-0423
UNII Not Available
Synonyms Antivenins | Anti-Venoms | Anti Venoms | Anti-Venin | Anti Venin | Anti-Venins | Anti Venins | Anti-Venom | Anti Venom | Antivenin | Antivenom | Antivenoms
Chemical Information
Molecular Formula Not Available
CAS Registry Number Not Available
SMILES Not Available
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaphylactic reaction10.01.07.001; 24.06.03.006--
Anxiety19.06.02.002--
Arthralgia15.01.02.001--
Cardiac arrest02.03.04.001--
Circulatory collapse24.06.02.001---
Cough22.02.03.001--
Cyanosis02.11.04.004; 22.02.02.007; 23.06.04.005; 24.03.01.007--
Death08.04.01.001--
Dyspnoea02.11.05.003; 22.02.01.004--
Face oedema08.01.07.003; 10.01.05.002; 23.04.01.004--
Flushing08.01.03.025; 23.06.05.003; 24.03.01.002--
Lymphadenopathy01.09.01.002---
Malaise08.01.01.003--
Muscular weakness15.05.06.001; 17.05.03.005--
Nausea07.01.07.001--
Oedema08.01.07.006; 14.05.06.010---
Pain08.01.08.004--
Pharyngeal oedema10.01.05.016; 22.04.05.003; 23.04.01.016---
Pyrexia08.05.02.003--
Shock24.06.02.002---
Tongue oedema07.14.02.007; 10.01.05.008; 23.04.01.009---
Urticaria10.01.06.001; 23.04.02.001--
Vomiting07.01.07.003--
The 1th Page    1    Total 1 Pages